Search results
AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
Zacks via Yahoo Finance· 6 days agoData from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective...
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 1 day agoAbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want...
Heads Up: Abbvie's Migraine Portfolio 'Very, Very Strong'
MediaPost· 18 hours agoIn the wake of Abbvie’s loss of exclusivity for its blockbuster Humira anti-inflammatory drug, its migraine-fighting meds -- Ubrelva, Qulipta and Botox -- have emerged as ...
AbbVie reports positive Phase II ovarian cancer trial data
Clinical Trials Arena via Yahoo Finance· 6 days agoAbbVie has reported positive topline data from the Phase II PICCOLO clinical trial of mirvetuximab...
Digital Medicine Society partners with pharma giants for new digital endpoints project
FierceBiotech· 23 hours agoAbbvie, Merck, Roche, Genentech, Regeneron, Sanofi and other big names in biopharma have signed on...
Pharma Stock Roundup: LLY's CFO Departs, ABBV, AZN Drugs Get CHMP Approval
Zacks via Yahoo Finance· 6 days agoAbbVie Starts Phase III Multiple Myeloma Study on BCMA Therapy, ABBV-383: AbbVie announced that it...
Geron wins long-sought drug approval; Califf talks China, GLP-1s at BIO
BioPharma Dive via Yahoo Finance· 6 days agoAfter 34 years, Geron finally has an approved medicine in Rytelo. Elsewhere, Shionogi disclosed...
RA Disease Activity Impacts Severity of Associated ILD
Medscape· 13 hours agoRheumatoid arthritis disease activity influenced the severity of interstitial lung disease, an associated comorbidity, thereby affecting patients' prognosis, showed study.
BioRestorative Therapies maintains its 'Buy' rating and $15 target price By Investing.com
Investing.com· 23 hours agoThe firm highlighted the company's solid financial standing, with $16.4 million in cash reserves at...
Oculis sees promise in dry eye disease subgroup, plans phase 3
FierceBiotech· 3 days agoOculis is forging ahead with its precision medicine approach to treating dry eye disease, outlining...